Concentrix Corporation (CNXC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNXC SEC filings page.
Concentrix Corporation (CNXC) reported $10.0B in revenue over the twelve months to Aug 31, 2026, up 2.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue barely advanced, but a large accounting loss and heavier leverage made FY2025 look far weaker than cash generation.
The cash-versus-earnings split is unusually wide: operating cash flow was$807M while net income was a$1.28B loss. Goodwill fell from$4.99B to$3.67B , so the combination suggests the reported loss was heavily influenced by a noncash balance-sheet charge rather than by cash operations alone.
Revenue increased only
Debt-to-equity rose from 1.2x to 1.7x as equity fell, showing that the same debt burden represented a larger claim on the balance sheet. The current ratio remained 1.4x, meaning short-term assets still exceeded near-term obligations, but the company had less equity cushion behind its leverage.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Concentrix Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Concentrix Corporation has an operating margin of -9.3%, meaning the company loses $9 on every $100 of revenue. This results in a profitability score of 30/100. This is down from 6.2% the prior year.
Concentrix Corporation's revenue grew a modest 2.2% year-over-year to $9.8B. This slow but positive growth earns a score of 79/100.
Concentrix Corporation has a moderate D/E ratio of 1.67. This balance of debt and equity financing earns a leverage score of 35/100.
Concentrix Corporation's current ratio of 1.40 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.
Concentrix Corporation has a free cash flow margin of 5.8%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.
Concentrix Corporation posts a -46.6% return on equity (ROE), meaning it loses $47 for every $100 of shareholders' equity. This results in a returns score of 26/100. This is down from 6.2% the prior year.
Concentrix Corporation scores 0.83, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Concentrix Corporation passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Concentrix Corporation reported a net loss of $1.3B while generating $807.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Concentrix Corporation reported an operating loss of $918.2M against $290.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Concentrix Corporation generated $2.5B in revenue in Q3 2026. This represents a decrease of 1.2% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.
Concentrix Corporation's EBITDA was -$752.8M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 338.6% from the same quarter a year earlier. Against the prior quarter it is down 394.6%.
Concentrix Corporation reported -$988.1M in net income in Q3 2026. This represents a decrease of 1221.5% from the same quarter a year earlier. Against the prior quarter it is down 1887.6%.
Concentrix Corporation earned -$16.24 per diluted share (EPS) in Q3 2026. This represents a decrease of 1311.9% from the same quarter a year earlier. Against the prior quarter it is down 1988.4%.
Cash & Balance Sheet
Concentrix Corporation generated $221.2M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 38.5% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.
Concentrix Corporation held $244.7M in cash against $3.9B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Concentrix Corporation's gross margin was 34.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
Concentrix Corporation's operating margin was -37.1% in Q3 2026, reflecting core business profitability. This is down 43.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 41.0 percentage points.
Concentrix Corporation's net profit margin was -40.3% in Q3 2026, showing the share of revenue converted to profit. This is down 43.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 42.5 percentage points.
Concentrix Corporation's ROE was -55.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 57.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 57.9 percentage points.
Capital Allocation
Concentrix Corporation repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
Concentrix Corporation invested $47.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 27.8% from the same quarter a year earlier. Against the prior quarter it is down 2.5%.
Not reported for Q3 2026.
CNXC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B-1.2% | $2.5B+1.9% | $2.5B+5.4% | $2.6B+4.3% | $2.5B+4.0% | $2.4B+1.5% | $2.4B-1.3% | $2.4B+9.7% |
| Cost of Revenue | $1.6B-1.4% | $1.6B+4.5% | $1.7B+8.9% | $1.7B+6.3% | $1.6B+6.9% | $1.6B+3.0% | $1.5B-1.9% | $1.6B+12.0% |
| Gross Profit | $848.9M-0.7% | $823.3M-2.9% | $849.7M-0.7% | $876.0M+0.6% | $855.0M-1.1% | $848.1M-1.1% | $855.9M-0.1% | $870.6M+5.8% |
| SG&A Expenses | $709.2M+0.2% | $727.9M+4.0% | $731.1M+6.4% | $730.6M+0.6% | $708.0M-0.4% | $699.8M-1.1% | $687.0M-3.0% | $726.1M+13.0% |
| Operating Income | -$910.3M-719.3% | $95.4M-35.7% | $118.6M-29.8% | -$1.4B-1056.4% | $147.0M-4.1% | $148.3M-1.2% | $168.9M+13.8% | $144.5M-19.9% |
| EBITDA | -$752.8M-338.6% | $255.5M-18.5% | $277.9M-15.7% | -$1.2B-488.3% | $315.5M-4.2% | $313.7M-4.1% | $329.6M-0.9% | $313.3M-24.4% |
| Interest Expense | $64.9M-9.9% | $68.1M-9.7% | $75.3M+3.2% | $69.9M-8.1% | $72.0M-10.9% | $75.4M-8.6% | $73.0M-11.5% | $76.1M+8.0% |
| Income Tax | $8.3M-64.2% | $14.2M+47.5% | $7.1M-76.6% | $33.2M+1310.1% | $23.3M+138.5% | $9.6M-52.6% | $30.5M+47.4% | -$2.7M-136.0% |
| Net Income | -$988.1M-1221.5% | $55.3M+31.3% | $21.6M-69.3% | -$1.5B-1379.2% | $88.1M+429.8% | $42.1M-37.0% | $70.3M+34.8% | $115.7M+66.4% |
| EPS (Basic) | -$16.24-1311.9% | $0.86+36.5% | $0.33-68.3% | -$23.37-1458.7% | $1.34+436.0% | $0.63-35.7% | $1.04+36.8% | $1.72+68.6% |
| EPS (Diluted) | -$16.24-1311.9% | $0.86+36.5% | $0.33-68.3% | -$23.37-1466.7% | $1.34+436.0% | $0.63-35.7% | $1.04+36.8% | $1.71+66.0% |
| Diluted Shares (Avg) | 61M-2.9% | 61M-4.0% | 61M-4.3% | N/A | 63M-3.2% | 63M-2.9% | 64M-2.6% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
CNXC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3B-25.4% | $10.5B-15.2% | $10.7B-10.3% | $10.8B-10.3% | $12.4B+1.7% | $12.4B+2.6% | $11.9B-2.8% | $12.0B-4.0% |
| Current Assets | $2.9B-7.0% | $3.0B-4.1% | $3.0B+2.7% | $3.1B+8.5% | $3.1B+10.1% | $3.2B+16.7% | $3.0B+6.4% | $2.8B-0.6% |
| Cash & Equivalents | $244.7M-30.1% | $255.6M-25.4% | $222.7M-27.7% | $327.3M+36.1% | $350.3M+42.2% | $342.8M+65.3% | $308.0M+31.2% | $240.6M-18.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $2.0B-4.0% | $2.0B-3.6% | $2.0B+1.2% | $2.0B+3.8% | $2.1B+6.0% | $2.1B+10.1% | $2.0B+4.5% | $1.9B+2.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $2.6B-49.2% | $3.7B-28.8% | $3.7B-25.1% | $3.7B-26.4% | $5.2B+2.1% | $5.1B+2.1% | $4.9B-1.9% | $5.0B-1.8% |
| Total Liabilities | $7.5B-7.1% | $7.8B-3.8% | $7.9B+0.3% | $8.0B+0.8% | $8.1B+0.3% | $8.1B+1.5% | $7.9B-3.4% | $8.0B-4.8% |
| Current Liabilities | $2.4B+18.0% | $2.6B+30.7% | $2.6B+43.7% | $2.2B+10.0% | $2.0B+10.9% | $2.0B+11.7% | $1.8B+0.5% | $2.0B-3.8% |
| Non-Current Liabilities | $5.1B-15.4% | $5.2B-14.8% | $5.3B-12.5% | $5.8B-2.3% | $6.1B-2.7% | $6.1B-1.4% | $6.1B-4.5% | $6.0B-5.1% |
| Long-Term Debt | $3.9B-18.1% | $3.9B-19.1% | $4.0B-18.5% | $4.6B-3.4% | $4.8B-2.4% | $4.9B-1.2% | $4.9B-2.6% | $4.7B-4.2% |
| Total Equity | $1.8B-59.3% | $2.7B-36.9% | $2.8B-30.9% | $2.7B-32.1% | $4.3B+4.2% | $4.3B+4.8% | $4.0B-1.7% | $4.0B-2.5% |
| Retained Earnings | -$1.2B-187.3% | -$146.5M-111.6% | -$178.6M-114.4% | -$177.0M-114.9% | $1.3B+20.6% | $1.3B+14.3% | $1.2B+17.4% | $1.2B+16.3% |
Not reported in any period shown, so not listed: Inventory.
CNXC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $268.2M+19.3% | $257.9M+9.0% | -$83.2M-6010.5% | $344.2M+21.0% | $224.8M+17.3% | $236.5M-0.8% | $1.4M+103.0% | $284.4M+24.0% |
| Depreciation & Amortization | $157.5M-6.6% | $160.1M-3.1% | $159.4M-0.8% | $165.9M-1.7% | $168.6M-4.3% | $165.3M-6.6% | $160.7M-12.7% | $168.7M+8.5% |
| Stock-Based Compensation | $21.8M-13.1% | $25.4M-5.6% | $27.7M+4.6% | N/A | $25.0M+10.5% | $26.9M+24.3% | $26.5M+22.8% | N/A |
| Capital Expenditures | $47.0M-27.8% | $48.2M-13.7% | $53.9M+6.5% | $63.0M+5.3% | $65.1M+3.7% | $55.8M-7.1% | $50.6M-9.7% | $59.9M-7.6% |
| Free Cash Flow | $221.2M+38.5% | $209.7M+16.0% | -$137.1M-178.6% | $281.2M+25.2% | $159.7M+24.0% | $180.7M+1.4% | -$49.2M+52.2% | $224.5M+36.5% |
| Investing Cash Flow | -$47.0M+27.8% | -$31.2M+44.2% | -$50.7M+1.0% | -$78.3M-28.6% | -$65.1M-3.7% | -$55.8M+7.1% | -$51.3M+15.3% | -$60.9M+96.9% |
| Financing Cash Flow | -$208.0M-26.2% | -$193.9M-30.2% | $18.5M-81.9% | -$280.0M-24.7% | -$164.8M-94.4% | -$148.9M+24.7% | $102.3M+608.3% | -$224.5M-234.9% |
| Dividends Paid | $23.2M+5.3% | $23.1M+4.4% | $23.1M+3.4% | $23.2M+2.6% | $22.0M+8.7% | $22.2M+9.0% | $22.4M+8.6% | $22.6M+9.8% |
| Share Buybacks | $0-100.0% | $0-100.0% | $43.2M+67.1% | $55.9M+62.2% | $41.6M+5.8% | $45.3M+11.6% | $25.8M+19.2% | $34.5M+56.6% |
CNXC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.6%+0.2pp | 33.4%-1.7pp | 34.0%-2.1pp | 34.3%-1.3pp | 34.4%-1.8pp | 35.1%-0.9pp | 36.1%+0.4pp | 35.6%-1.3pp |
| Operating Margin | -37.1%-43.0pp | 3.9%-2.3pp | 4.7%-2.4pp | -54.1%-60.1pp | 5.9%-0.5pp | 6.1%-0.2pp | 7.1%+0.9pp | 5.9%-2.2pp |
| Net Margin | -40.3%-43.8pp | 2.2%+0.5pp | 0.9%-2.1pp | -58.0%-62.7pp | 3.5%+2.8pp | 1.7%-1.1pp | 3.0%+0.8pp | 4.7%+1.6pp |
| Return on Equity | -55.9%-57.9pp | 2.1%+1.1pp | 0.8%-1.0pp | -53.9%-56.8pp | 2.0%+1.6pp | 1.0%-0.7pp | 1.7%+0.5pp | 2.9%+1.2pp |
| Return on Assets | -10.7%-11.4pp | 0.5%+0.2pp | 0.2%-0.4pp | -13.8%-14.7pp | 0.7%+0.6pp | 0.3%-0.2pp | 0.6%+0.2pp | 1.0%+0.4pp |
| Current Ratio | 1.23-0.3x | 1.18-0.4x | 1.18-0.5x | 1.400.0x | 1.560.0x | 1.61+0.1x | 1.65+0.1x | 1.420.0x |
| Debt-to-Equity | 2.22+1.1x | 1.46+0.3x | 1.43+0.2x | 1.67+0.5x | 1.10-0.1x | 1.14-0.1x | 1.220.0x | 1.170.0x |
| Asset Turnover | 0.27+0.1x | 0.230.0x | 0.230.0x | 0.240.0x | 0.200.0x | 0.200.0x | 0.200.0x | 0.200.0x |
| FCF Margin | 9.0%+2.6pp | 8.5%+1.0pp | -5.5%-3.4pp | 11.0%+1.8pp | 6.4%+1.0pp | 7.5%0.0pp | -2.1%+2.2pp | 9.2%+1.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Concentrix Corporation CNXC | FY2025 | $9.8B | -$1.3B | -13.0% | $1.7B | 43/100 |
| WNS (Holdings) Limited WNS | FY2025 | $1.3B | $170.1M | 12.9% | $3.3B | 67/100 |
| Clarivate Plc CLVT | FY2025 | $2.5B | -$201.1M | -8.2% | $940.3M | 29/100 |
| Verra Mobility Corporation VRRM | FY2025 | $979.1M | $136.6M | 14.0% | $443.8M | 65/100 |
| GLOBANT S.A. GLOB | FY2025 | $2.5B | $104.0M | 4.2% | $1.5B | 44/100 |
| DXC Technology Company DXC | FY2026 | $12.6B | $18.0M | 0.1% | $1.9B | 54/100 |
Where Concentrix Corporation Ranks
Frequently Asked Questions
What is Concentrix Corporation's annual revenue?
Concentrix Corporation (CNXC) reported $9.8B in total revenue for fiscal year 2025. This represents a 2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Concentrix Corporation's revenue growing?
Concentrix Corporation (CNXC) revenue grew by 2.2% year-over-year, from $9.6B to $9.8B in fiscal year 2025.
Is Concentrix Corporation profitable?
No, Concentrix Corporation (CNXC) reported a net income of -$1.3B in fiscal year 2025, with a net profit margin of -13.0%.
What is Concentrix Corporation's EBITDA?
Concentrix Corporation (CNXC) had EBITDA of -$257.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Concentrix Corporation have?
As of fiscal year 2025, Concentrix Corporation (CNXC) had $327.3M in cash and equivalents against $4.6B in long-term debt.
What is Concentrix Corporation's gross margin?
Concentrix Corporation (CNXC) had a gross margin of 35.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Concentrix Corporation's operating margin?
Concentrix Corporation (CNXC) had an operating margin of -9.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Concentrix Corporation's net profit margin?
Concentrix Corporation (CNXC) had a net profit margin of -13.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Concentrix Corporation's return on equity (ROE)?
Concentrix Corporation (CNXC) has a return on equity of -46.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Concentrix Corporation's free cash flow?
Concentrix Corporation (CNXC) generated $572.5M in free cash flow during fiscal year 2025. This represents a 33.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Concentrix Corporation's operating cash flow?
Concentrix Corporation (CNXC) generated $807.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Concentrix Corporation's total assets?
Concentrix Corporation (CNXC) had $10.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Concentrix Corporation's capital expenditures?
Concentrix Corporation (CNXC) invested $234.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Concentrix Corporation's current ratio?
Concentrix Corporation (CNXC) had a current ratio of 1.40 as of fiscal year 2025, which is considered adequate.
What is Concentrix Corporation's debt-to-equity ratio?
Concentrix Corporation (CNXC) had a debt-to-equity ratio of 1.67 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Concentrix Corporation's return on assets (ROA)?
Concentrix Corporation (CNXC) had a return on assets of -11.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Concentrix Corporation's P/E ratio?
Concentrix Corporation (CNXC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to August 31, 2026). The market capitalization is $1.7B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Concentrix Corporation's price-to-sales ratio?
Concentrix Corporation (CNXC) trades at 0.2x sales, its market capitalization divided by revenue of $10.0B revenue, trailing 12 months to August 31, 2026. The market capitalization is $1.7B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Concentrix Corporation's Altman Z-Score?
Concentrix Corporation (CNXC) has an Altman Z-Score of 0.83, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Concentrix Corporation's Piotroski F-Score?
Concentrix Corporation (CNXC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Concentrix Corporation's earnings high quality?
Concentrix Corporation (CNXC) reported a net loss of $1.3B while generating $807.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Concentrix Corporation cover its interest payments?
Concentrix Corporation (CNXC) reported an operating loss of $918.2M against $290.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Concentrix Corporation?
Concentrix Corporation (CNXC) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.